Last year, CCF team members Stacie Lindsey and Melinda Bachini along with colleagues in the field Rachna Shroff, MD, FASCO and Wendy Selig, authored the #whitepaper "Cross-over arms in oncology clinical trials: An important consideration for patients," highlighting a revolutionary approach to designing cancer clinical trials. The paper emphasizes the importance of patient-centric trial designs and introduces the concept of "cross-over" options, opening new doors for patients with limited treatment options. It also encourages sponsors, investigators, and regulators to advance patient-centric trial designs. This initiative is crucial for our CCF community as it represents a significant step forward in #cholangiocarcinoma cancer research and patient care. Read more about the whitepaper here: https://lnkd.in/eRJ_TY3h. #CCAhope #cureCCA #bileductcancer #ClinicalTrials #NationalCancerResearchMonth #PatientPoweredResearch See less
Cholangiocarcinoma Foundation’s Post
More Relevant Posts
-
Phase 1 oncology trials occupy a unique space in the clinical trial landscape. They have distinct study designs tailored to meet the needs of product development and terminally ill patients. Learn more about how these trials are paving the way for groundbreaking advancements in cancer care: https://hubs.li/Q02Zvk-W0 #OncologyTrials #Phase1 #EarlyPhase #Phase1OncologyTrials
-
-
Talent Acquisition Manager at TFS HealthScience ✨✨ Strategic Talent Partner Driving Success in Clinical Research Recruitment ✨✨
Are you interested in hearing about strategies on how to enhancing efficiency in early phase oncology trials? Click below to register for the event where our experts Bin Pan and Mike Mendoza will be sharing their thoughts and experiences on this topic. #TFSHealthScience #TFSCRO #EarlyPhaseOncologyTrials #ClinicalTrials #AcceleratingDataFlow #Oncology
Ready to take your early-phase oncology trials to the next level? Join us as our experts share cutting-edge strategies for accelerating data flow. Register today to enhance efficiency and tackle challenges with confidence. Don't miss this opportunity to stay at the forefront of clinical research and advance cancer treatment. Register today: https://lnkd.in/edYf-MFA #OncologyCRO #EarlyPhaseOncologyTrials #ClinicalTrials
-
-
Data is king - but how? Join our webinar to learn.
Ready to take your early-phase oncology trials to the next level? Join us as our experts share cutting-edge strategies for accelerating data flow. Register today to enhance efficiency and tackle challenges with confidence. Don't miss this opportunity to stay at the forefront of clinical research and advance cancer treatment. Register today: https://lnkd.in/edYf-MFA #OncologyCRO #EarlyPhaseOncologyTrials #ClinicalTrials
-
-
Access to #precision #oncology is essential to ensure optimal and timely treatment of patients with cancer. However, challenges to access precision oncology highlight disparities across countries in Europe. The various precision oncology multi-stakeholder initiatives led by the European Commission can help address the challenges faced by cancer patients and healthcare providers at a country level. Join us on 13 November to explore how we can optimize the link between European initiatives and local challenges: https://lnkd.in/d4Fbakca
-
-
➖ QUARTERLY REPORT ➖ #Amplia has today released its Quarterly Activities and Cash Flow Report for the quarter ended 30 June 2024. Key highlights for the quarter include: ✔ Updated data and analysis from the Phase 1b ACCENT trial in pancreatic cancer presented at the prestigious annual meetings of the American Association for Cancer Research (AACR) and the American Society of Clinical Oncology (ASCO) ✔ Recruitment in the ACCENT Phase 2a trial has progressed well and in early June we reported 24 of 26 patients had been recruited. ✔ The inaugural meeting of the Company’s Clinical Advisory Board was held. Read today’s ASX release here 👉 https://lnkd.in/gtiCG5QN $ATX #ASX #research #innovation #cancerresearch #pancreaticcancer #clinicaltrial
-
-
Imagine the possibilities if we could expand the rate of enrollment in #ClinicalTrials from its current 5%? It’s a prospect that oncologist Mark Lee, PhD, MD, has not only considered but is working to realize by focusing on the community oncology arena. We spoke with Dr. Lee during the most recent #AVBCC Educational Summit & Program about the barriers to clinical trial enrollment in the community oncology setting, and how his company, N-Power Medicine, Inc., is partnering with these practices to provide the infrastructure, technology, and staff they need to become powerful research centers. Do you have thoughts on increasing clinical trial enrollment? Share them with us in the comments below. Hear more on this and other hot topics affecting value-based cancer care at #AVBCC2024, taking place October 16-18 in New York City. Register today and join the conversation either in person or virtually: https://bit.ly/46z7yAH We look forward to your ideas and insight! #Cancer #OncologyCare #ValueBasedCancerCare #HealthcareLeaders #ClinicalTrials #ClinicalTrialEnrollment #DrugDevelopment #Research #Oncology #Oncologists
-
Ready to find a cure for your complex challenge? LabConnect's expertise in oncology can help accelerate your clinical trial.
At LabConnect, we understand the importance of timely and accurate specimen collection in #oncology clinical trials. Our expertise in oncology trials ensures that every step is carefully managed to support early and effective cancer treatment. We’re dedicated to optimizing data endpoints to enhance safety and efficacy, ultimately driving better outcomes for patients like Naomi. Partner with the experts at LabConnect to accelerate your oncology research and bring hope to those who need it most. => https://lnkd.in/gGS5K55z #LabConnect #ClinicalTrials #OncologyResearch
-
-
Ready to find a cure for your complex challenge? LabConnevt’s expertise in oncology can help accelerate your clinical trial.
At LabConnect, we understand the importance of timely and accurate specimen collection in #oncology clinical trials. Our expertise in oncology trials ensures that every step is carefully managed to support early and effective cancer treatment. We’re dedicated to optimizing data endpoints to enhance safety and efficacy, ultimately driving better outcomes for patients like Naomi. Partner with the experts at LabConnect to accelerate your oncology research and bring hope to those who need it most. => https://lnkd.in/gGS5K55z #LabConnect #ClinicalTrials #OncologyResearch
-
-
Achieving equity in lung cancer screening is an imperative. Work led by Shanada Monestime, PharmD, BCOP and #GO2forLungCancer provides insight on an approach to attain equity in lung cancer screening. #LCSM #LungCancer #HOPA2024
GO2’s Director, Community Engaged Research Shanada Monestime, PharmD, BCOP, presented at the Hematology/Oncology Pharmacy Association (HOPA)'s annual meeting this week. She shared her study, “Unlocking Geographic Disparities in Lung Cancer Incidence Calls for Tailored Interventions and Pharmacist Partnerships,” that identifies counties with significant disparities in lung cancer. The study found that it is critical to establish partnerships with pharmacists in communities such as Washington, D.C., North Carolina, and Virginia to customize screening interventions to increase lung cancer screening rates: https://bit.ly/3J9wljN #LCSM #LungCancer #HOPA2024
-
-
The Cleveland Genitourinary Oncology Consortium Meeting, hosted by the University Hospitals Seidman Center and the Cleveland Clinic Taussig Cancer Center, took place on October 16, 2024. This collaborative event gathered healthcare professionals, researchers, and specialists to discuss the latest research findings, treatment protocols, and innovations in genitourinary oncology. Shilpa Gupta, MD Christopher Wee, MD Pedro C Barata, MD MSc FACP Laura Bukavina MD MPH MSc Moshe Ornstein Beth Elsass Here are some highlights from the event: https://lnkd.in/e-WS6P9W #OncoDaily #Oncology #Cancer #Health #Medicine #CancerCare #OncologyResearch
-
